Rhythm Biosciences Limited

ASX:RHY Stock Report

Market Cap: AU$32.3m

Rhythm Biosciences Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Rhythm Biosciences.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Healthcare earnings growth26.1%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Is Rhythm Biosciences (ASX:RHY) In A Good Position To Deliver On Growth Plans?

Dec 06
Is Rhythm Biosciences (ASX:RHY) In A Good Position To Deliver On Growth Plans?

We're Not Very Worried About Rhythm Biosciences' (ASX:RHY) Cash Burn Rate

Aug 09
We're Not Very Worried About Rhythm Biosciences' (ASX:RHY) Cash Burn Rate

We're Hopeful That Rhythm Biosciences (ASX:RHY) Will Use Its Cash Wisely

Apr 11
We're Hopeful That Rhythm Biosciences (ASX:RHY) Will Use Its Cash Wisely

Here's Why We're Not Too Worried About Rhythm Biosciences' (ASX:RHY) Cash Burn Situation

Dec 02
Here's Why We're Not Too Worried About Rhythm Biosciences' (ASX:RHY) Cash Burn Situation

We're Hopeful That Rhythm Biosciences (ASX:RHY) Will Use Its Cash Wisely

Jul 19
We're Hopeful That Rhythm Biosciences (ASX:RHY) Will Use Its Cash Wisely

Here's Why We're Not Too Worried About Rhythm Biosciences' (ASX:RHY) Cash Burn Situation

Mar 03
Here's Why We're Not Too Worried About Rhythm Biosciences' (ASX:RHY) Cash Burn Situation

Do Institutions Own Rhythm Biosciences Limited (ASX:RHY) Shares?

Dec 03
Do Institutions Own Rhythm Biosciences Limited (ASX:RHY) Shares?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Rhythm Biosciences has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

ASX:RHY - Analysts future estimates and past financials data (AUD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/20242-7-6-6N/A
3/31/20242-8-7-7N/A
12/31/20232-9-8-8N/A
9/30/20233-8-8-8N/A
6/30/20233-8-7-7N/A
3/31/20233-8-7-7N/A
12/31/20223-8-6-6N/A
9/30/20223-9-6-6N/A
6/30/20222-9-7-6N/A
3/31/20222-9-6-6N/A
12/31/20212-9-6-6N/A
9/30/20212-8-6-6N/A
6/30/20211-7-5-5N/A
3/31/20211-5-4-4N/A
12/31/20201-4-3-3N/A
9/30/20201-4-3-3N/A
6/30/20200-4-3-3N/A
3/31/20200-4-3-3N/A
12/31/20191-3-3-3N/A
9/30/20191-3-3-3N/A
6/30/20191-3-3-3N/A
3/31/20191-3-3-3N/A
12/31/20180-3-2-2N/A
9/30/20180-2-2-2N/A
6/30/2018N/A-2-2-2N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if RHY's forecast earnings growth is above the savings rate (2.6%).

Earnings vs Market: Insufficient data to determine if RHY's earnings are forecast to grow faster than the Australian market

High Growth Earnings: Insufficient data to determine if RHY's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if RHY's revenue is forecast to grow faster than the Australian market.

High Growth Revenue: Insufficient data to determine if RHY's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if RHY's Return on Equity is forecast to be high in 3 years time


Discover growth companies